We are live on
!
Find out more
LBC
Lawrence B. Cohen Portfolio holdings
AUM
$2.06M
1-Year Est. Return
34.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.87%
1 Year Est. Return
+34.47%
3 Year Est. Return
+41.85%
5 Year Est. Return
+126.65%
10 Year Est. Return
+272.7%
AUM
$140M
AUM Growth
+$8.26M
(+6.2%)
Cap. Flow
-$4.12M
Cap. Flow
% of AUM
-2.93%
Top 10 Holdings %
Top 10 Hldgs %
42.18%
Holding
74
New
2
Increased
5
Reduced
46
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$824K |
| 2 |
Home Depot
HD
|
+$314K |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$198K |
| 4 |
US Bancorp
USB
|
+$163K |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$48.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$864K |
| 2 |
Microsoft
MSFT
|
+$790K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$330K |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$222K |
| 5 |
CVS Health
CVS
|
+$207K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Healthcare | 21.05% |
| 3 | Consumer Staples | 14.32% |
| 4 | Energy | 13.25% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $9.9M | 7.05% |
53,594
-1,865
| -3% | -$330K |
|
|
2
Microsoft
MSFT
$3.37T
| $6.51M | 4.63% |
173,923
-21,742
| -11% | -$790K |
|
3
Intel
INTC
$467B
| $6.45M | 4.6% |
248,672
-2,530
| -1% | -$61.2K |
|
4
PepsiCo
PEP
$190B
| $6.25M | 4.45% |
75,325
-1,825
| -2% | -$152K |
|
|
BHI
5
DELISTED
Baker Hughes
BHI
| $5.26M | 3.75% |
95,250
-1,425
| -1% | -$78K |
|
6
Stryker
SYK
$124B
| $5.24M | 3.74% |
69,784
-1,550
| -2% | -$113K |
|
7
Apple
AAPL
$4.45T
| $4.99M | 3.55% |
248,948
-196
| -0.1% | -$3.7K |
|
8
Procter & Gamble
PG
$333B
| $4.98M | 3.55% |
61,162
-530
| -0.9% | -$43.2K |
|
9
Walmart Inc
WMT
$888B
| $4.93M | 3.51% |
188,049
-6,150
| -3% | -$159K |
|
|
RDS.B
10
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.7M | 3.35% |
62,576
+691
| +1% | +$48.6K |
|
11
Qualcomm
QCOM
$156B
| $4.57M | 3.26% |
61,578
-340
| -0.5% | -$24K |
|
12
3M
MMM
$90.5B
| $4.5M | 3.21% |
38,396
-1,622
| -4% | -$173K |
|
13
Abbott
ABT
$181B
| $4.26M | 3.04% |
111,277
-1,550
| -1% | -$57.1K |
|
14
iShares MSCI EAFE ETF
EFA
$77.7B
| $4.24M | 3.02% |
63,226
-660
| -1% | -$43.1K |
|
15
Medtronic
MDT
$108B
| $4.18M | 2.98% |
72,800
-2,500
| -3% | -$142K |
|
16
ExxonMobil
XOM
$632B
| $4.03M | 2.87% |
39,847
-1,225
| -3% | -$113K |
|
17
Corning
GLW
$121B
| $4.01M | 2.86% |
225,195
-1,525
| -0.7% | -$25.1K |
|
|
18
Edwards Lifesciences
EW
$49.5B
| $3.76M | 2.68% |
343,140
+73,080
| +27% | +$824K |
|
19
Johnson & Johnson
JNJ
$615B
| $3.66M | 2.61% |
39,987
-2,015
| -5% | -$186K |
|
20
Applied Materials
AMAT
$406B
| $3.63M | 2.59% |
205,300
-8,600
| -4% | -$150K |
|
21
Gilead Sciences
GILD
$161B
| $3.6M | 2.57% |
48,000
| – | – |
|
22
Emerson Electric
EMR
$83.3B
| $3.27M | 2.33% |
46,530
-1,020
| -2% | -$68.1K |
|
|
23
US Bancorp
USB
$97.8B
| $3.12M | 2.22% |
77,300
+4,250
| +6% | +$163K |
|
24
Equinor
EQNR
$96.3B
| $2.57M | 1.83% |
106,673
-7,870
| -7% | -$182K |
|
25
Target
TGT
$65.2B
| $2.08M | 1.49% |
32,957
-2,125
| -6% | -$136K |
|
Similar funds
ICM
TA
SCM
LCMP
GIP
STC
GC
DU
Lawrence B. Cohen's Q4 2013 Portfolio in Review
As of Q4 2013, Lawrence B. Cohen held 74 positions worth $140M, up 6.2% from $132M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Lawrence B. Cohen's Q4 2013 filing shows 2 new, 5 increased, 46 reduced and 5 closed positions. Its largest new stake was Home Depot: 4,025 shares worth $331K. The largest sale was Teva Pharmaceuticals, an estimated $864K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
- Lawrence B. Cohen's largest Q4 2013 buy was Home Depot: 4,025 shares worth $331K.
- Lawrence B. Cohen added most to Edwards Lifesciences in Q4 2013, an estimated $824K increase.
- Lawrence B. Cohen's biggest Q4 2013 reduction was Microsoft, cutting an estimated $790K.
- Lawrence B. Cohen fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $864K.
- Lawrence B. Cohen's ten largest holdings make up 42% of its $140M portfolio in Q4 2013.
- Lawrence B. Cohen opened 2 new positions and closed 5 in Q4 2013.
- Lawrence B. Cohen's portfolio value rose 6.2% quarter-over-quarter to $140M.
Based on Lawrence B. Cohen's 13F filing for Q4 2013, filed 10 Feb 2014.